Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
The key themes that defined the year behind us will also shape the one ahead. The most-read articles of 2025 tracked a return ...
What are the differences between how AI systems handle JavaScript-rendered or interactively hidden content compared to ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
This is a summary of: Liu. H. et al. Viral RNA blocks circularization to evade host codon usage control. Nature https://doi.org/10.1038/s41586-025-09809-y (2025).
Open WebUI carried CVE-2025-64496, a high-severity code injection flaw in Direct Connection features Exploitation could ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback